All
6 August 2026
Vedanta Biosciences Secures $60 Million in Funding and Strengthens Leadership Team Ahead of Pivotal Phase 3 Data
Vedanta Biosciences, a late clinical-stage biopharmaceutical company developing microbiome-based oral therapies for gastrointestinal diseases, today announced securing $60...
23 July 2026
Another milestone for Reboat, a French pioneer in sailboat refurbishment: Seventure Partners takes a stake in the company to accelerate its growth
Reboat announces the closing of a funding round led by Seventure Partners, alongside existing investors and business angels, including Charlotte Souleau, Managing Director for...
21 July 2026
Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with progression-free survival in patients with indolent non-Hodgkin lymphoma in the watch-and-wait setting
Enterome SA, a clinical-stage company pioneering OncoMimics™, a new class of off-the-shelf, multi-targeted in vivo immune therapies, today announced new positive interim data...
29 June 2026
Wultra Raises €6.8 Million in Series A Funding to Accelerate Global Expansion of Post-Quantum Digital Identity Solutions
Wultra, a provider of post-quantum authentication and digital identity solutions for banks and fintechs, announced the completion of a €6.8 million Series A funding round....
9 June 2026
Infomedia Announces Acquisition of Veact in Europe, Expanding Global Automotive Aftersales Ecosystem
Infomedia, a global leader in automotive aftersales technology, has completed the acquisition of Veact GmbH, a leading European provider of data activation, predictive service...
28 May 2026
Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma
Enterome SA, a clinical-stage company pioneering OncoMimics™, a new class of off-the-shelf, multi-targeted in vivo immune therapies, today announced that the U.S. Food and...
27 May 2026
vorteX-io raises €8.5 million to make hydrological data a driver of national sovereignty
VorteX -io Raises €8.5 Million from Seventure Partners, Banque des Territoires, and Daphni to Turn Hydrological Data into a Lever for National Sovereignty and Address Global...
19 May 2026
Social AdTech firm Mediads raises €3 million to accelerate its expansion into the US
Mediads, a pioneering social adtech company since 2022 specialising in social publishing, which
offers a platform designed to boost the performance of
18 May 2026
Microbiotica reports positive results for MB097 in advanced melanoma
Data suggests microbiome co-therapy may help overcome resistance to anti‑PD‑1 treatment.
Microbiotica has announced positive findings from its phase 1b MELODY‑1...